USD 2.98 billion
Report ID:
SQMIG35H2224 |
Region:
Global |
Published Date: September, 2024
Pages:
157
|Tables:
89
|Figures:
76
Immunohistochemistry Market size was valued at around USD 2.9 billion in 2022 and is expected to rise from USD 3.1 billion in 2023 to reach a value of USD 5.5 billion by 2031, at a CAGR of 7.4% over the forecast period (2024–2031).
Rapidly increasing prevalence of chronic diseases around the world and high investments in the development of novel diagnostic products and technologies are slated to bolster immunohistochemistry market growth. The growing use of immunohistochemistry in drug discovery and development processes is also expected to offer lucrative new business scope for immunohistochemistry providers going forward. High adoption and acceptance of companion diagnostics are also forecasted to create new opportunities for immunohistochemistry companies in the future. Rapid advancements in diagnostics technologies are also projected to favor immunohistochemistry demand outlook in the long run. On the contrary, the dearth of skilled professionals, high costs of immunohistochemistry equipment, and risk of false positives are some key constraints that could hinder the demand for immunohistochemistry across the study period and beyond. High demand for early diagnosis and growing awareness regarding advanced diagnostic technologies will also create new opportunities for immunohistochemistry providers in the long run.
US Immunohistochemistry Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 2.98 billion
Largest Segment
hospitals and diagnostic laboratories
Fastest Growth
hospitals and diagnostic laboratories
Growth Rate
7.4% CAGR
To get more reports on the above market click here to Buy The Report
Global Immunohistochemistry Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Antibodies (Primary antibodies, Secondary antibodies) clonality (Monoclonal antibodies, Polyclonal antibodies), Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Organic Solvents, Proteolytic Enzymes, Diluents, Other Reagents (Antigen Retrieval Solutions, Stabilizers, Controls, And Mounting Solutions)), Equipment (Slide-staining Systems, Tissue Processing Systems, Slide Scanners, Other Equipment (Digital Pathology Systems And Histology Equipment, Such As Automated Cover Slippers, Visualization Equipment (Bright-Field, Fluorescence Microscopes), Microtomes, Paraffin Dispensers, Slide Labelers, And Tissue Microarrays)), Kits (Human Immunohistochemistry Kits, Animal Immunohistochemistry Kits). Based on Application, the market is segmented into Application Diagnostic applications (Cancer, Infectious diseases, Autoimmune diseases, Nephrological diseases, Neurological diseases, Other diseases (Ophthalmic, Cardiovascular, Dermatological, And Dental Diseases), Research applications (Drug Development and Testing, Other research applications (Stem Cell Research and Developmental Biology), and Forensic applications. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories, Academic Institutions & Contract Research Organizations (CROs), Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Immunohistochemistry Market Analysis by Product
Antibodies are projected to account for a substantial share of the global immunohistochemistry market. Growing investments in drug discovery and development is a prime factor that helps the dominance of this segment. Rising use of monoclonal antibodies, antibody drug conjugates, etc. In multiple healthcare applications is also expected to help this segment maintain its high market share across the forecast period. The high use of antibodies in pathology, neuropathology, and hematopathology applications will also create new opportunities for market growth via this segment.
On the other hand, the demand for immunohistochemistry kits is projected to surge at an impressive pace over the coming years. The rising use of immunohistochemistry kits in multiple research programs and growing preference for immunohistochemistry kits among researchers around the world are also helping this segment bring in major revenue. Surging investments in multiple medical R&D and convenience and ease of use offered by immunohistochemistry kits will also favor market growth going forward.
Immunohistochemistry Market Analysis by End User
Hospitals and diagnostic laboratories are projected to spearhead the demand for immunohistochemistry across the study period owing to rising volume of immunohistochemistry diagnostic tests performed in these establishments. Rising hospitalization rates, growing chronic disease prevalence, and high preference for immunohistochemistry diagnostic tests are also helping this segment maintain its dominant market share.
Meanwhile, the demand for immunohistochemistry in academic institutes & contract research organizations is projected to increase at an impressive pace going forward. The rapid surge in investments in medical research around the world is a prime factor that helps this segment become an opportune one. Increasing adoption of immunohistochemistry by multiple researchers will also further create new opportunities for market players via this segment.
To get detailed analysis on other segments, Request For Free Sample Report
North America is projected to account for a dominant share of the global immunohistochemistry market. The presence of a strong medical research infrastructure, supportive government funding for research, and rising demand for early diagnostics are forecasted to create new opportunities for immunohistochemistry market players. The United States is projected to lead the demand for immunohistochemistry in this region owing to the presence of multiple pharmaceutical and biotechnology companies in the country. Canada is also expected to provide lucrative opportunities for immunohistochemistry companies as demand for better diagnostic products increases.
The Asia-Pacific region is emerging as the fastest-growing market for immunohistochemistry companies in the world. Growing awareness regarding early diagnosis, high demand for advanced diagnostic procedures, and increasing healthcare expenditure are making this region a highly opportune one for all immunohistochemistry companies. Rising spending on medical R&D in countries such as Japan, China, and India along with supportive government funding is expected to bolster the demand for immunohistochemistry in this region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Immunohistochemistry Market Drivers
Growing Incidence of Chronic Diseases
Rising Demand for Personalized Medicine
Restraints
High Costs of Immunohistochemistry Equipment and Consumables
Dearth of Skilled Professionals
Request Free Customization of this report to help us to meet your business objectives.
Investing in the development of immunohistochemistry-based diagnostics will be the most rewarding opportunity for any market player. Creating affordable immunohistochemistry solutions that can be used by establishments with limited budgets will help immunohistochemistry companies expand their business in developing countries going forward. New product launches and collaborations are slated to be popular strategies for all immunohistochemistry companies.
Immunohistochemistry Market Top Player’s Company Profiles
Immunohistochemistry Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, the future prospects of the immunohistochemistry (IHC) market are promising. Factors such as the increasing prevalence of chronic diseases, rising demand for personalized medicine, and advancements in diagnostic techniques are expected to drive market growth. Additionally, the growing focus on precision medicine and targeted therapies is fueling the demand for IHC assays in drug development and patient stratification. Technological advancements, such as multiplex IHC and digital pathology, are further enhancing the capabilities of IHC, allowing for more comprehensive analysis and interpretation of tissue samples. Moreover, the expanding applications of IHC in research and clinical settings, along with the emergence of novel biomarkers, present significant opportunities for market expansion. With ongoing advancements and innovations, the IHC market is poised for continued growth in the coming years.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 2.9 billion |
Market size value in 2031 | USD 5.5 billion |
Growth Rate | 7.4% |
Base year | 2023 |
Forecast period | 2024–2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Immunohistochemistry Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunohistochemistry Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunohistochemistry Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Immunohistochemistry Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2224
sales@skyquestt.com
USA +1 351-333-4748